Back to results
US 2024/0181070 A1Published application
Nanovaccines for treatment of viral diseases
AssigneeRamot at Tel-Aviv University Ltd.
InventorsRonit SATCHI-FAINARO, Helena FLORINDO
Life of this patent
Estimating the term…
Abstract
A polymeric nanoparticle is disclosed which comprises: (i) at least one SARS-CoV-2 derived antigen which is capable of producing a T-cell and/or B cell response: and (ii) an antigen presenting cell targeting moiety which is attached to the outer surface of the nanoparticle. Use of the nanoparticle for treating COVID-19 is also disclosed.
Claims33
A polymeric nanoparticle comprising:
- (i) at least one SARS-CoV-2 derived antigen which is capable of producing a B-cell and/or a T-cell response;
- and
- (ii) an antigen presenting cell targeting moiety which is attached to the outer surface of the nanoparticle.
(canceled)
(canceled)
8-18. (canceled)
22-25. (canceled)
27-28. (canceled)
30-31. (canceled)
33-34. (canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.